시장보고서

상품코드

1908412

야누스 키나아제(Jak) 억제제 시장(2026-2030년)

Global Janus Kinase (Jak) Inhibitors Market 2026-2030

발행일: 2026년 01월 | 리서치사:

TechNavio | 페이지 정보: 영문 280 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 야누스 키나아제(JAK) 억제제 시장은 2925-2030년의 예측 기간에 CAGR 23.1%로 성장하여 252억 5,710만 달러 규모에 이를 것으로 예측되고 있습니다. 본 세계의 야누스 키나아제(JAK) 억제제 시장 보고서에서는 종합적 분석, 시장 규모와 예측, 동향, 성장요인, 과제에 가세해 약 25개사 벤더 분석을 제공합니다.

본 보고서는 현재 시장 상황, 최신 동향 및 성장요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 자가면역질환 및 염증성 질환의 유병률 증가, 경구 투여를 통한 환자의 복약 순응도 및 편의성 향상, 개인 맞춤형 의료 및 표적 치료로의 전환이 시장을 주도하고 있습니다.

이번 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보의 객관적인 조합을 통해 이루어졌습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 포함되어 있습니다.

시장 범위
기준 연도	2026년
종료 연도	2030년
예측 기간	2026-2030
성장 모멘텀	가속
YOY 2026	19.5%
CAGR	23.1%
증가액	252억 5,710만 달러

이 보고서는 향후 몇 년 동안 세계 자누스 키나아제(JAK) 억제제 시장의 성장을 주도할 주요 요인 중 하나로 제품 혁신을 주도할 기술 혁신을 꼽았습니다. 또한, 동형체 선택적 차세대 JAK 억제제의 등장과 효과 향상을 위한 병용요법 증가는 시장에서 상당한 수요를 창출할 것으로 예측됩니다.

기업 개요
기업 순위 지표
기업의 시장 포지셔닝
AbbVie Inc.
Aclaris Therapeutics Inc.
Ajax Therapeutics Inc.
Alexion Pharmaceuticals Inc.
Arcutis Biotherapeutics Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Bristol Myers Squibb Co.
Celon Pharma SA
Eli Lilly and Co.
Gilead Sciences Inc.
GlaxoSmithKline Plc
Incyte Corp.
Novartis AG
Pfizer Inc.

제16장 부록

LSH 26.01.29

The global janus kinase (jak) inhibitors market is forecasted to grow by USD 25257.1 mn during 2025-2030, accelerating at a CAGR of 23.1% during the forecast period. The report on the global janus kinase (jak) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of autoimmune and inflammatory diseases, oral dosing improves patient adherence and convenience, shift toward personalized medicine and targeted therapies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2026
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	19.5%
CAGR	23.1%
Incremental Value	$25257.1 mn

Technavio's global janus kinase (jak) inhibitors market is segmented as below:

By Application

Autoimmune disorders
Oncology

By Product Type

JAK1 selective inhibitors
JAK2 selective inhibitors
JAK3 selective inhibitors

By Route Of Administration

Oral tablets
Injectable therapies
Topical formulations

Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the technological breakthroughs driving product innovation traction as one of the prime reasons driving the global janus kinase (jak) inhibitors market growth during the next few years. Also, rise of isoform-selective next-gen jak inhibitors and increase in combination therapies for enhanced efficacy will lead to sizable demand in the market.

The report on the global janus kinase (jak) inhibitors market covers the following areas:

Global janus kinase (jak) inhibitors market sizing
Global janus kinase (jak) inhibitors market forecast
Global janus kinase (jak) inhibitors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global janus kinase (jak) inhibitors market vendors that include AbbVie Inc., Aclaris Therapeutics Inc., Ajax Therapeutics Inc., Alexion Pharmaceuticals Inc., Arcutis Biotherapeutics Inc., Astellas Pharma Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Celon Pharma SA, Eli Lilly and Co., Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., Novartis AG, Pfizer Inc., Swedish Orphan Biovitrum AB, Takeda Pharmaceutical Ltd.. Also, the global janus kinase (jak) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Chart on Market characteristics analysis
3.3 Value chain analysis
- Chart on Value chain analysis

4 Market Sizing

4.1 Market definition
- Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5 Historic Market Size

5.1 Global Janus Kinase (JAK) Inhibitors Market 2020 - 2024
- Historic Market Size - Data Table on Global Janus Kinase (JAK) Inhibitors Market 2020 - 2024 ($ million)
5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.3 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
5.4 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 The AI Impact on Global Janus Kinase (JAK) inhibitors Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Autoimmune disorders - Market size and forecast 2025-2030
- Chart on Autoimmune disorders - Market size and forecast 2025-2030 ($ million)
- Data Table on Autoimmune disorders - Market size and forecast 2025-2030 ($ million)
- Chart on Autoimmune disorders - Year-over-year growth 2025-2030 (%)
- Data Table on Autoimmune disorders - Year-over-year growth 2025-2030 (%)
8.4 Oncology - Market size and forecast 2025-2030
- Chart on Oncology - Market size and forecast 2025-2030 ($ million)
- Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
- Chart on Oncology - Year-over-year growth 2025-2030 (%)
- Data Table on Oncology - Year-over-year growth 2025-2030 (%)
8.5 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Product Type

9.1 Market segments
- Chart on Product Type - Market share 2025-2030 (%)
- Data Table on Product Type - Market share 2025-2030 (%)
9.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
9.3 JAK1 selective inhibitors - Market size and forecast 2025-2030
- Chart on JAK1 selective inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on JAK1 selective inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on JAK1 selective inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on JAK1 selective inhibitors - Year-over-year growth 2025-2030 (%)
9.4 JAK2 selective inhibitors - Market size and forecast 2025-2030
- Chart on JAK2 selective inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on JAK2 selective inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on JAK2 selective inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on JAK2 selective inhibitors - Year-over-year growth 2025-2030 (%)
9.5 JAK3 selective inhibitors - Market size and forecast 2025-2030
- Chart on JAK3 selective inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on JAK3 selective inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on JAK3 selective inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on JAK3 selective inhibitors - Year-over-year growth 2025-2030 (%)
9.6 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Oral tablets - Market size and forecast 2025-2030
- Chart on Oral tablets - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral tablets - Market size and forecast 2025-2030 ($ million)
- Chart on Oral tablets - Year-over-year growth 2025-2030 (%)
- Data Table on Oral tablets - Year-over-year growth 2025-2030 (%)
10.4 Injectable therapies - Market size and forecast 2025-2030
- Chart on Injectable therapies - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable therapies - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable therapies - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable therapies - Year-over-year growth 2025-2030 (%)
10.5 Topical formulations - Market size and forecast 2025-2030
- Chart on Topical formulations - Market size and forecast 2025-2030 ($ million)
- Data Table on Topical formulations - Market size and forecast 2025-2030 ($ million)
- Chart on Topical formulations - Year-over-year growth 2025-2030 (%)
- Data Table on Topical formulations - Year-over-year growth 2025-2030 (%)
10.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2025-2030
  - Chart on US - Market size and forecast 2025-2030 ($ million)
  - Data Table on US - Market size and forecast 2025-2030 ($ million)
  - Chart on US - Year-over-year growth 2025-2030 (%)
  - Data Table on US - Year-over-year growth 2025-2030 (%)
- 12.3.2 Canada - Market size and forecast 2025-2030
  - Chart on Canada - Market size and forecast 2025-2030 ($ million)
  - Data Table on Canada - Market size and forecast 2025-2030 ($ million)
  - Chart on Canada - Year-over-year growth 2025-2030 (%)
  - Data Table on Canada - Year-over-year growth 2025-2030 (%)
- 12.3.3 Mexico - Market size and forecast 2025-2030
  - Chart on Mexico - Market size and forecast 2025-2030 ($ million)
  - Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
  - Chart on Mexico - Year-over-year growth 2025-2030 (%)
  - Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.4 Europe - Market size and forecast 2025-2030
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2025-2030
  - Chart on Germany - Market size and forecast 2025-2030 ($ million)
  - Data Table on Germany - Market size and forecast 2025-2030 ($ million)
  - Chart on Germany - Year-over-year growth 2025-2030 (%)
  - Data Table on Germany - Year-over-year growth 2025-2030 (%)
- 12.4.2 UK - Market size and forecast 2025-2030
  - Chart on UK - Market size and forecast 2025-2030 ($ million)
  - Data Table on UK - Market size and forecast 2025-2030 ($ million)
  - Chart on UK - Year-over-year growth 2025-2030 (%)
  - Data Table on UK - Year-over-year growth 2025-2030 (%)
- 12.4.3 France - Market size and forecast 2025-2030
  - Chart on France - Market size and forecast 2025-2030 ($ million)
  - Data Table on France - Market size and forecast 2025-2030 ($ million)
  - Chart on France - Year-over-year growth 2025-2030 (%)
  - Data Table on France - Year-over-year growth 2025-2030 (%)
- 12.4.4 Italy - Market size and forecast 2025-2030
  - Chart on Italy - Market size and forecast 2025-2030 ($ million)
  - Data Table on Italy - Market size and forecast 2025-2030 ($ million)
  - Chart on Italy - Year-over-year growth 2025-2030 (%)
  - Data Table on Italy - Year-over-year growth 2025-2030 (%)
- 12.4.5 Spain - Market size and forecast 2025-2030
  - Chart on Spain - Market size and forecast 2025-2030 ($ million)
  - Data Table on Spain - Market size and forecast 2025-2030 ($ million)
  - Chart on Spain - Year-over-year growth 2025-2030 (%)
  - Data Table on Spain - Year-over-year growth 2025-2030 (%)
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
  - Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
  - Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
  - Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
  - Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
12.5 Asia - Market size and forecast 2025-2030
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2025-2030
  - Chart on China - Market size and forecast 2025-2030 ($ million)
  - Data Table on China - Market size and forecast 2025-2030 ($ million)
  - Chart on China - Year-over-year growth 2025-2030 (%)
  - Data Table on China - Year-over-year growth 2025-2030 (%)
- 12.5.2 Japan - Market size and forecast 2025-2030
  - Chart on Japan - Market size and forecast 2025-2030 ($ million)
  - Data Table on Japan - Market size and forecast 2025-2030 ($ million)
  - Chart on Japan - Year-over-year growth 2025-2030 (%)
  - Data Table on Japan - Year-over-year growth 2025-2030 (%)
- 12.5.3 India - Market size and forecast 2025-2030
  - Chart on India - Market size and forecast 2025-2030 ($ million)
  - Data Table on India - Market size and forecast 2025-2030 ($ million)
  - Chart on India - Year-over-year growth 2025-2030 (%)
  - Data Table on India - Year-over-year growth 2025-2030 (%)
- 12.5.4 South Korea - Market size and forecast 2025-2030
  - Chart on South Korea - Market size and forecast 2025-2030 ($ million)
  - Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
  - Chart on South Korea - Year-over-year growth 2025-2030 (%)
  - Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- 12.5.5 Indonesia - Market size and forecast 2025-2030
  - Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
  - Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
  - Chart on Indonesia - Year-over-year growth 2025-2030 (%)
  - Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- 12.5.6 Thailand - Market size and forecast 2025-2030
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Brazil - Market size and forecast 2025-2030
  - Chart on Brazil - Market size and forecast 2025-2030 ($ million)
  - Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
  - Chart on Brazil - Year-over-year growth 2025-2030 (%)
  - Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  - Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  - Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  - Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
  - Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- 12.6.3 UAE - Market size and forecast 2025-2030
  - Chart on UAE - Market size and forecast 2025-2030 ($ million)
  - Data Table on UAE - Market size and forecast 2025-2030 ($ million)
  - Chart on UAE - Year-over-year growth 2025-2030 (%)
  - Data Table on UAE - Year-over-year growth 2025-2030 (%)
- 12.6.4 Turkey - Market size and forecast 2025-2030
  - Chart on Turkey - Market size and forecast 2025-2030 ($ million)
  - Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
  - Chart on Turkey - Year-over-year growth 2025-2030 (%)
  - Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- 12.6.5 Argentina - Market size and forecast 2025-2030
  - Chart on Argentina - Market size and forecast 2025-2030 ($ million)
  - Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
  - Chart on Argentina - Year-over-year growth 2025-2030 (%)
  - Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- 12.6.6 Colombia - Market size and forecast 2025-2030
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- 12.6.7 South Africa - Market size and forecast 2025-2030
  - Chart on South Africa - Market size and forecast 2025-2030 ($ million)
  - Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
  - Chart on South Africa - Year-over-year growth 2025-2030 (%)
  - Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- 12.6.8 Israel - Market size and forecast 2025-2030
  - Chart on Israel - Market size and forecast 2025-2030 ($ million)
  - Data Table on Israel - Market size and forecast 2025-2030 ($ million)
  - Chart on Israel - Year-over-year growth 2025-2030 (%)
  - Data Table on Israel - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Rising prevalence of autoimmune and inflammatory diseases
- Oral dosing improves patient adherence and convenience
- Shift toward personalized medicine and targeted therapies
13.2 Market challenges
- Safety concerns due to serious adverse
- High treatment costs limit patient accessibility
- Stringent regulatory approvals slow market entry
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Technological breakthroughs driving product innovation traction
- Rise of isoform-selective next-gen JAK inhibitors
- Increase in combination therapies for enhanced efficacy

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Aclaris Therapeutics Inc.
- Aclaris Therapeutics Inc. - Overview
- Aclaris Therapeutics Inc. - Product / Service
- Aclaris Therapeutics Inc. - Key offerings
- SWOT
15.6 Ajax Therapeutics Inc.
- Ajax Therapeutics Inc. - Overview
- Ajax Therapeutics Inc. - Product / Service
- Ajax Therapeutics Inc. - Key offerings
- SWOT
15.7 Alexion Pharmaceuticals Inc.
- Alexion Pharmaceuticals Inc. - Overview
- Alexion Pharmaceuticals Inc. - Product / Service
- Alexion Pharmaceuticals Inc. - Key offerings
- SWOT
15.8 Arcutis Biotherapeutics Inc.
- Arcutis Biotherapeutics Inc. - Overview
- Arcutis Biotherapeutics Inc. - Product / Service
- Arcutis Biotherapeutics Inc. - Key news
- Arcutis Biotherapeutics Inc. - Key offerings
- SWOT
15.9 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.10 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
15.11 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.12 Celon Pharma SA
- Celon Pharma SA - Overview
- Celon Pharma SA - Product / Service
- Celon Pharma SA - Key offerings
- SWOT
15.13 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
15.14 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT
15.15 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
15.16 Incyte Corp.
- Incyte Corp. - Overview
- Incyte Corp. - Product / Service
- Incyte Corp. - Key offerings
- SWOT
15.17 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.18 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

야누스 키나아제(Jak) 억제제 시장(2026-2030년)

Global Janus Kinase (Jak) Inhibitors Market 2026-2030

목차

제1장 주요 요약

제2장 Technavio 분석

제3장 시장 구도

제4장 시장 규모

제5장 시장 규모 실적

제6장 정성 분석

제7장 Five Forces 분석

제8장 시장 세분화 : 용도별

제9장 시장 세분화 : 제품 유형별

제10장 시장 세분화 : 투여 경로별

제11장 고객 상황

제12장 지역별 상황

제13장 촉진요인, 과제 및 기회

제14장 경쟁 구도

제15장 경쟁 분석